Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 60505-2656

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 60505-2656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

37-5mg-25mg-btl (37 5mg 25mg Btl)

37-5mg-25mg-btl (37 5mg 25mg Btl)
This is a description of a medication called Triamterene and Hydrochlorothiazide. Each tablet contains 375 mg of Triamterene and 25mg of Hydrochlorothiazide. It should be stored at a temperature between 20°C-25°C, with excursions allowed between 15°C-30°C, and kept away from light. The medication should be dispensed in a child-resistant container. The usual dosage is indicated in the package insert. The medication is manufactured by Apotex Inc. in Toronto, Ontario, Canada, and is sold in bottles of 100 tablets.*
FDA Label Image

75mg-50mg-btl (75mg 50mg Btl)

75mg-50mg-btl (75mg 50mg Btl)
Triamterene and Hydrochlorothiazide Tablets, USP is a prescription medication used to treat high blood pressure and fluid retention. Each tablet contains 75 mg of Triamterene, USP and 50 mg of Hydrochlorothiazide, USP. It should be stored at room temperature between 20°C to 25°C (68°F to 77°F), and protected from light. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The usual dosage should be determined by consultin the package insert. This particular package contains 100 tablets and the NDC number is 60505-2657-1. This medication is manufactured by Apotex Inc. located in Toronto, Canada, and is distributed by Apotex Corp. located in Weston, Florida.*
FDA Label Image

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)
This text provides information about the chemical compound CHCIN, including its molecular weight of 297.73.*
FDA Label Image

Structure-triamterene (Structure Triamterene)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.